2021-01-11, KINTOR PHARMA-B: Proxalutamide Significantly Inhibits Condition of Male COVID-19 Patients  
2020-12-14,   《HKEx》- 09939 KINTOR PHARMA-B - VOLUNTARY ANNOUNCEMENT FINAL RESULTS FOR MALE PATIENTS AND INTERIM RESULTS FOR FEMALE PATIENTS FROM THE CLINICAL TRIAL OF PROXALUTAMIDE FOR THE TREATMENT OF COVID-19 
2020-12-12,   《HKEx》- 09939 KINTOR PHARMA-B - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020 
2020-11-21,"   《HKEx》- 09939 KINTOR PHARMA-B - VOLUNTARY ANNOUNCEMENT
COMPLETION OF PATIENTS ENROLMENT FOR
PYRILUTAMIDE (KX-826)''S PHASE II
CLINICAL TRIAL FOR INDICATION OF
ANDROGENETIC ALOPECIA IN THE PRC "
2020-09-18,   《HKEx》- 09939 KINTOR PHARMA-B - LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS 
